175 related articles for article (PubMed ID: 34310103)
1. T-cell and Antibody Response After 2 Doses of the BNT162b2 Vaccine in a Belgian Cohort of Kidney Transplant Recipients.
Devresse A; Saad Albichr I; Georgery H; Yombi JC; De Greef J; Belkhir L; Mzougui S; Scohy A; Darius T; Buemi A; Goffin E; Kabamba B; Kanaan N
Transplantation; 2021 Oct; 105(10):e142-e143. PubMed ID: 34310103
[No Abstract] [Full Text] [Related]
2. Very Low Immunization Rate in Kidney Transplant Recipients After One Dose of the BNT162b2 Vaccine: Beware not to Lower the Guard!
Georgery H; Devresse A; Yombi JC; Belkhir L; De Greef J; Darius T; Buemi A; Scohy A; Kabamba B; Goffin E; Kanaan N
Transplantation; 2021 Oct; 105(10):e148-e149. PubMed ID: 33988543
[No Abstract] [Full Text] [Related]
3. Humoral and cellular immunity to delayed second dose of SARS-CoV-2 BNT162b2 mRNA vaccination in patients with cancer.
McKenzie DR; Muñoz-Ruiz M; Monin L; Alaguthurai T; Lechmere T; Abdul-Jawad S; Graham C; Pollock E; Graham R; Sychowska K; Seow J; Tremain C; Gousis C; Domingo-Vila C; Cooper J; Vidler J; Owczarczyk K; Swampillai A; Kristeleit H; Malim MH; Fields P; Patten PEM; Papa S; North BV; Tree T; Doores KJ; Hayday AC; Irshad S
Cancer Cell; 2021 Nov; 39(11):1445-1447. PubMed ID: 34678151
[No Abstract] [Full Text] [Related]
4. Repeated vaccination against SARS-CoV-2 elicits robust polyfunctional T cell response in allogeneic stem cell transplantation recipients.
Harrington P; Doores KJ; Saha C; Saunders J; Child F; Dillon R; Saglam S; Raj K; McLornan D; Avenoso D; Kordasti S; O'Reilly A; Espehana A; Lechmere T; Khan H; Malim MH; Harrison C; Mehra V; de Lavallade H
Cancer Cell; 2021 Nov; 39(11):1448-1449. PubMed ID: 34717827
[No Abstract] [Full Text] [Related]
5. Poor humoral and T-cell response to two-dose SARS-CoV-2 messenger RNA vaccine BNT162b2 in cardiothoracic transplant recipients.
Schramm R; Costard-Jäckle A; Rivinius R; Fischer B; Müller B; Boeken U; Haneya A; Provaznik Z; Knabbe C; Gummert J
Clin Res Cardiol; 2021 Aug; 110(8):1142-1149. PubMed ID: 34241676
[TBL] [Abstract][Full Text] [Related]
6. Variable cellular responses to SARS-CoV-2 in fully vaccinated patients with multiple myeloma.
Aleman A; Upadhyaya B; Tuballes K; Kappes K; Gleason CR; Beach K; Agte S; Srivastava K; ; Van Oekelen O; Barcessat V; Bhardwaj N; Kim-Schulze S; Gnjatic S; Brown B; Cordon-Cardo C; Krammer F; Merad M; Jagannath S; Wajnberg A; Simon V; Parekh S
Cancer Cell; 2021 Nov; 39(11):1442-1444. PubMed ID: 34706273
[No Abstract] [Full Text] [Related]
7. Impaired humoral and cellular immunity after SARS-CoV-2 BNT162b2 (tozinameran) prime-boost vaccination in kidney transplant recipients.
Sattler A; Schrezenmeier E; Weber UA; Potekhin A; Bachmann F; Straub-Hohenbleicher H; Budde K; Storz E; Proß V; Bergmann Y; Thole LM; Tizian C; Hölsken O; Diefenbach A; Schrezenmeier H; Jahrsdörfer B; Zemojtel T; Jechow K; Conrad C; Lukassen S; Stauch D; Lachmann N; Choi M; Halleck F; Kotsch K
J Clin Invest; 2021 Jul; 131(14):. PubMed ID: 34101623
[TBL] [Abstract][Full Text] [Related]
8. Antibody and T Cell Response to SARS-CoV-2 Messenger RNA BNT162b2 Vaccine in Kidney Transplant Recipients and Hemodialysis Patients.
Bertrand D; Hamzaoui M; Lemée V; Lamulle J; Hanoy M; Laurent C; Lebourg L; Etienne I; Lemoine M; Le Roy F; Nezam D; Plantier JC; Boyer O; Guerrot D; Candon S
J Am Soc Nephrol; 2021 Sep; 32(9):2147-2152. PubMed ID: 34112706
[TBL] [Abstract][Full Text] [Related]
9. Humoral Response after SARS-CoV-2 mRNA Vaccination in a Cohort of Hemodialysis Patients and Kidney Transplant Recipients.
Danthu C; Hantz S; Dahlem A; Duval M; Ba B; Guibbert M; El Ouafi Z; Ponsard S; Berrahal I; Achard JM; Bocquentin F; Allot V; Rerolle JP; Alain S; Touré F
J Am Soc Nephrol; 2021 Sep; 32(9):2153-2158. PubMed ID: 34135083
[TBL] [Abstract][Full Text] [Related]
10. Assessment of humoral and cellular immunity induced by the BNT162b2 SARS-CoV-2 vaccine in healthcare workers, elderly people, and immunosuppressed patients with autoimmune disease.
Malipiero G; Moratto A; Infantino M; D'Agaro P; Piscianz E; Manfredi M; Grossi V; Benvenuti E; Bulgaresi M; Benucci M; Villalta D
Immunol Res; 2021 Dec; 69(6):576-583. PubMed ID: 34417958
[TBL] [Abstract][Full Text] [Related]
11. Cellular and Humoral Immune Responses After 3 Doses of BNT162b2 mRNA SARS-CoV-2 Vaccine in Kidney Transplant.
Stumpf J; Tonnus W; Paliege A; Rettig R; Steglich A; Gembardt F; Kessel F; Kröger H; Arndt P; Sradnick J; Frank K; Tonn T; Hugo C
Transplantation; 2021 Nov; 105(11):e267-e269. PubMed ID: 34342963
[TBL] [Abstract][Full Text] [Related]
12. Impact of Kidney Transplantation on Humoral Immunity Against SARS-CoV-2: A Case Series From Belgium.
Fernandes G; Devresse A; Scohy A; Yombi JC; Belkhir L; De Greef J; De Meyer M; Mourad M; Darius T; Buemi A; Kabamba B; Goffin E; Kanaan N
Transplantation; 2021 Nov; 105(11):e257-e258. PubMed ID: 34347716
[No Abstract] [Full Text] [Related]
13. Antibody Response to the Janssen COVID-19 Vaccine in Solid Organ Transplant Recipients.
Boyarsky BJ; Chiang TP; Ou MT; Werbel WA; Massie AB; Segev DL; Garonzik-Wang JM
Transplantation; 2021 Aug; 105(8):e82-e83. PubMed ID: 34098566
[No Abstract] [Full Text] [Related]
14. Seroresponse to SARS-CoV-2 Vaccines among Maintenance Dialysis Patients over 6 Months.
Hsu CM; Weiner DE; Manley HJ; Aweh GN; Ladik V; Frament J; Miskulin D; Argyropoulos C; Abreo K; Chin A; Gladish R; Salman L; Johnson D; Lacson EK
Clin J Am Soc Nephrol; 2022 Mar; 17(3):403-413. PubMed ID: 35144972
[TBL] [Abstract][Full Text] [Related]
15. Serological Response to the BNT162b2 COVID-19 mRNA Vaccine in Adolescent and Young Adult Kidney Transplant Recipients.
Haskin O; Ashkenazi-Hoffnung L; Ziv N; Borovitz Y; Dagan A; Levi S; Koren G; Hamdani G; Levi-Erez D; Landau D; Alfandary H
Transplantation; 2021 Nov; 105(11):e226-e233. PubMed ID: 34381004
[TBL] [Abstract][Full Text] [Related]
16. Effect of previous SARS-CoV-2 infection on humoral and T-cell responses to single-dose BNT162b2 vaccine.
Prendecki M; Clarke C; Brown J; Cox A; Gleeson S; Guckian M; Randell P; Pria AD; Lightstone L; Xu XN; Barclay W; McAdoo SP; Kelleher P; Willicombe M
Lancet; 2021 Mar; 397(10280):1178-1181. PubMed ID: 33640037
[No Abstract] [Full Text] [Related]
17. SARS-CoV-2-specific T cell immunity to structural proteins in inactivated COVID-19 vaccine recipients.
Deng Y; Li Y; Yang R; Tan W
Cell Mol Immunol; 2021 Aug; 18(8):2040-2041. PubMed ID: 34267334
[No Abstract] [Full Text] [Related]
18. Evaluation of the Immune Response Induced by CoronaVac 28-Day Schedule Vaccination in a Healthy Population Group.
Escobar A; Reyes-López FE; Acevedo ML; Alonso-Palomares L; Valiente-Echeverría F; Soto-Rifo R; Portillo H; Gatica J; Flores I; Nova-Lamperti E; Barrera-Avalos C; Bono MR; Vargas L; Simon V; Leiva-Salcedo E; Vial C; Hormazabal J; Cortes LJ; Valdés D; Sandino AM; Imarai M; Acuña-Castillo C
Front Immunol; 2021; 12():766278. PubMed ID: 35173705
[TBL] [Abstract][Full Text] [Related]
19. Humoral Response to mRNA versus an Adenovirus Vector-Based SARS-CoV-2 Vaccine in Dialysis Patients.
Mulhern JG; Fadia A; Patel R; Ficociello LH; Willetts J; Dahne-Steuber IA; Pollan MC; Mullon C; DeLisi J; Johnson C; Mysayphonh C; Kossmann RJ; Anger MS; Hymes JL
Clin J Am Soc Nephrol; 2021 Nov; 16(11):1720-1722. PubMed ID: 34312162
[No Abstract] [Full Text] [Related]
20. Humoral Response of Renal Transplant Recipients to the BNT162b2 SARS-CoV-2 mRNA Vaccine Using Both RBD IgG and Neutralizing Antibodies.
Hod T; Ben-David A; Olmer L; Levy I; Ghinea R; Mor E; Lustig Y; Rahav G
Transplantation; 2021 Nov; 105(11):e234-e243. PubMed ID: 34310101
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]